AZNCF (AstraZeneca) Other Stockholders Equity : $1,859 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is AstraZeneca Other Stockholders Equity?

AstraZeneca's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $1,859 Mil.

AstraZeneca's quarterly Other Stockholders Equity declined from Jun. 2024 ($2,078 Mil) to Sep. 2024 ($1,990 Mil) and declined from Sep. 2024 ($1,990 Mil) to Dec. 2024 ($1,859 Mil).

AstraZeneca's annual Other Stockholders Equity declined from Dec. 2022 ($1,916 Mil) to Dec. 2023 ($1,912 Mil) and declined from Dec. 2023 ($1,912 Mil) to Dec. 2024 ($1,859 Mil).

AstraZeneca Other Stockholders Equity Historical Data

The historical data trend for AstraZeneca's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Other Stockholders Equity Chart

AstraZeneca Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

1,871.00

1,892.00

1,916.00

1,912.00

1,859.00

AstraZeneca Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial															1,912.00	2,075.00	2,078.00	1,990.00	1,859.00

AstraZeneca Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

AstraZeneca Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (OTCPK:AZNCF) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

AZN:USA AZN:Sweden AZN1:Mexico AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil AZN:Argentina

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.